The objective of the law is to establish an institutional framework for regulating the pharmaceutical sector to ensure market approval and use of pharmaceutical products that are accessible, safe, efficient, and of appropriate quality (art.2). It notably establishes the Authority for pharmaceutical regulation (Autorité Ivoirienne de Regulation Pharmaceutique - AIRP) and addresses its mandates (chapter 1).
The Code provides for the "Caisse Nationale de Prévoyance Sociale" (CNPS) whose tasked is to provide benefits to salaried employees to alleviate the financial consequences of certain risks or situations such as accident at work and occupational diseases, maternity, retirement, invalidity and death and family allowances (art. 1 and 5).